EW - Edwards Lifesciences Non-GAAP EPS of $0.64 in-line revenue of $1.53B beats by $30M
2024-02-06 16:20:14 ET
More on Edwards Lifesciences
- Edward Lifesciences: Still Not A Buy But Getting Closer
- Edwards Lifesciences: Undervalued With A Substantial Upside Potential
- Edwards Lifesciences Q4 2023 Earnings Preview
- Edwards stock jumps 8% on FDA approval, Wells Fargo upgrade
- Seeking Alpha’s Quant Rating on Edwards Lifesciences